Neurons of the central nervous system (CNS) form a magnificent network destined to control bodily functions and human behavior for a lifetime. During development of the CNS, neurons extend axons that establish connections to other neurons. Axon growth is guided by extrinsic cues and guidance molecules. In addition to environmental signals, intrinsic programs including transcription and the ubiquitin proteasome system (UPS) have been implicated in axon growth regulation. Over the past few years it has become evident that the E3 ubiquitin ligase Cdh1-APC together with its associated pathway plays a central role in axon growth suppression. By elucidating the intricate interplay of extrinsic and intrinsic mechanisms, we can enhance our understanding of why axonal regeneration in the CNS fails and obtain further insight into how to stimulate successful regeneration after injury.
Introduction
Neurodevelopment is a fundamental process involving axonal and dendritic growth to establish a functional neuronal network. Axon growth is crucial for making the appropriate connections with the target tissue. A large body of research in the neurodevelopment field led to advanced knowledge of various mechanisms underlying axon growth and guidance. During development of the nervous system, growth cones of neurons act as sensors to sample the environment for cues that promote axon growth and lead the way to the target area [1] [2] [3] .
The growth cone harbors conserved receptors, which distinguish between attractive and repellent axon growth stimuli. Guidance cues including Netrins, Semaphorins and Slits, which bind to the respective Unc-5 or DCC, Plexin and Robo receptors direct outgrowing axons [4] [5] [6] [7] [8] .
Further essential regulators of axon growth and guidance in the brain are Neurotrophins such as NGF and BDNF, which bind to Trk receptors and Ephrins together with Eph receptors [9] [10] [11] [12] .
Adhesion molecules are also crucial for axonal contact with its environment to ultimately establish a functional network [13, 14] .
Once fully developed, the CNS in contrast to the peripheral nervous system (PNS) has very little capacity for axonal repair and regeneration following brain or spinal cord injury [15, 16] . Apart from damage to axonal tracts, CNS injury inevitably destroys surrounding structures like myelin and induces unfavorable responses by glial cells [15] . To date, we have a good understanding of the mechanisms that inhibit axonal regeneration as the major culprits have been extensively studied: Myelin components including Nogo, MAG (myelin associated protein) or OMGp (oligodendrocyte myelin glycoprotein)
represent strong inhibitors of successful regeneration [17] [18] [19] [20] . In addition, inflammation, formation of a glial scar, and chondroitin sulfate proteoglycans (CSPGs) create a hostile environment, which inhibits regeneration and CNS recovery [21] [22] [23] . Notably, the small GTPase RhoA does not only play a major role in axon growth during development but also during axonal regeneration [24] [25] [26] . Several of the axon growth-inhibiting mechanisms, e.g.
those triggered by axonal contact of the NogoReceptor complex with myelin proteins and CSPGs, converge on RhoA, which negatively regulates the microtubule cytoskeleton [24] [25] [26] [27] [28] .
Hence, besides overcoming myelin inhibition and recreating a permissive environment to stimulate reinnervation, Rho signaling has been the focus of regeneration models such as spinal cord injury and optic nerve crush, and in the treatment of CNS injuries [29] [30] [31] [32] [33] [34] .
Taken together, brain damage exposes axons to a milieu that is no longer supporting axonal health and growth but consists of a plethora of inhibitory components, which thwart any attempt of recovery.
Overview over intrinsic regulation of axon growth and regeneration
In addition to the unfavorable environment, it has become increasingly clear that the intrinsic potential of neurons to grow axons declines with neuronal maturation. Studies of retinal neurons proved that while young neurons have the potential to extend long axons, older neurons fail to efficiently grow axons [35, 36] .
These findings posed another significant obstacle to axonal regeneration and thus ignited the search for intrinsic regulators of axon growth, which stimulate axon growth and possibly regeneration.
Owing to its pivotal role in axon growth, the growth cone is equipped with a sophisticated and tailored set of receptors. Over the past decade, a large body of evidence has emerged in support of transcriptional control of axon growth and guidance [37, 38] . Several transcription factors have been identified to control the expression of receptors at the growth cone, which results in the intrinsic programming of the neuron's response to its environment [39] . Eph/ephrin and Trk are examples of crucial guidance receptors whose developmental expression is precisely regulated by homeobox transcription factors and Runx1, respectively [40] [41] [42] . Consistent with this concept of transcriptional control of axon growth, gene expression patterns associated with axon growth are very different in neurons when they are young as compared to when they are mature [43] . Similar to neuronal maturation, CNS injury also triggers a change in gene expression that affects axon growth and regeneration [44] . For example the transcription factor Krüppel-like factor 4 (KLF4), a suppressor of axon growth, is upregulated in mature neurons [43] . Consequently, deletion of KLF4 stimulates axon growth of cultured retinal neurons and axonal regeneration after optic nerve injury [43] . Injury-induced upregulation of Smad1 gene expression turned out to be beneficial to axon growth as the activation of Smad1 by BMP4 was found to efficiently promote axon growth in spinal cord injury [44, 45] . and Phosphatase and tensin homolog (PTEN), respectively [46, 47] . Simultaneous deletion of SOC3 and PTEN proved to be an even more potent promoter of regeneration in an optic nerve injury model [48, 49] [50] . By stabilizing microtubules with low doses of the microtubule-stabilizing agent Taxol, the growth cone cytoarchitecture can be reshaped and axons could even overcome myelin inhibition [50] . Taxol has also proven to stimulate axonal regeneration in models of spinal and optic nerve injury [51, 52] . by targeting the transcription factor lin-14 [57] . lin-14 is part of a regulatory loop that facilitates the regeneration of young neurons by downregulation of the miR let-7 [58] . In older neurons, lin-14 fails to support axonal regeneration owing to its downregulation by miR let-7 [58] . In mammals, miR-9 has been implicated in axon growth by regulating the microtubule binding protein MAP1b [59] . Mammalian mir-124 targets the mRNA of the small GTPase RhoG and thus promotes axonal branching [60] . These studies indicate that temporal regulation and fine-tuning of axon guidance is controlled by micro RNAs. Not surprisingly, miRs also take part in axonal regeneration. Here, miR-133b targets RhoA and promotes functional recovery after spinal cord injury in adult zebrafish [61] . promotes axon growth in adult dorsal root ganglion neurons [63] . Among the microRNAs, that are upregulated in dorsal root ganglia after nerve injury, miR-222 was identified and found to target PTEN [64] , suggesting that the injuryresponse disengages inhibitory mechanisms to stimulate regeneration in the PNS, which could be useful in designing therapies for CNS injuries.
Further epigenetic mechanisms, which include the modifications of histones, are rather unexplored but emerging evidence indicates a role in axon growth and regeneration.
The histone acetyl transferases CBP/p300 and P/CAF appear to activate axon growthstimulating transcriptional programs [65] . In an optic nerve crush model, expression of p300, which is downregulated in mature retinal ganglion neurons, has beneficial effects on axonal regeneration [66] . 
UPS-controlled axon growth
The UPS is unequivocally one of the most complex machineries of the cell and is certainly an uncharted area in neurodevelopmental biology. E1 ubiquitin-activating and E2-ubiquitin-conjugating enzymes together with E3 ligases constitute an enzymatic cascade that facilitates the ubiquitination of target proteins [67] . elegans (aka rpm-1), where it affects trafficking of Robo and unc receptors [80] . Also, after axotomy in C. elegans, Phr1-deficient motor neurons regenerate more e ciently [81] . [86] . Given the large number of UPS components, future research is likely to establish a great role of the UPS in axon growth regulation and regeneration.
The Cdh1-APC pathway of intrinsic inhibition of axon growth
The large multisubunit E3 ligase Anaphase
Promoting complex (APC) is of crucial importance for rapidly removing key proteins during mitosis by proteasomal degradation to facilitate smooth cell cycle transitions [87, 88] .
While the RING subunit APC11 binds the E2-ubiquitin conjugate, the subunits Cdh1 and of SnoN [103] . Furthermore, phosphorylated
Smads and low levels of SnoN in neurons are
indicative of active TGFβ signaling [103] . As a consequence of pharmacological inhibition of TGFβ signaling, SnoN becomes stabilized and axon growth is significantly enhanced [103] .
Interestingly, Smad2 RNAi overcomes myelin inhibition of axon growth, which suggests a decreased sensitivity of axons to repulsive myelin components [103] . Collectively, these findings established an interaction of the Cdh1-APC and TGFβ signaling pathways and indicate a crosstalk of extrinsic cues with intrinsic pathways of axon growth ( Figure 3A) .
In addition to SnoN, Lasorella and colleagues identified the transcription factor Id2 as another nuclear substrate of Cdh1-APC, [104] .
Id2 inhibits the E protein E47, which in turn controls the expression of axon growthinhibiting genes such as Nogo Receptor, Sema3F
and Unc5A [104] . Consequently, expression of E47 suppresses the axon growth-stimulating effect of both Cdh1 RNAi and the stabilized Id2 D-box mutant [104] . Collectively, these studies identified Id2 as a crucial target of Cdh1-APC, which critically regulates the expression of axon guidance receptors that alter the sensitivity of the growth cone ( Figure 3A) .
Apart from extrinsic factors affecting the
Cdh1-APC pathway, phosphorylation of Cdh1 seems to play a significant role in axon growth regulation. Cdh1 has several highly conserved Cdk phosphorylation sites, which not only regulate binding of Cdh1 to the APC core [105] and Cdh1's localization but interestingly also the stability of Cdh1 [106] .
The latter can be recapitulated by treatment of neurons with the Cdk inhibitor Roscovitine, which leads to destabilization of Cdh1 [106] .
A hyperphosphorylated, stabilized mutant of Cdh1 is unable to restrict axon growth as it localizes predominantly in the cytoplasm and it fails to interact with the core complex [106] .
A role for Cdk5 e.g. in axonal growth and axon formation has been previously shown [107] , but Cdk5 appears to have little or no benefit in axon regeneration [108] . Phosphorylation of Cdh1 by Cdks might thus plays a greater role in development as compared to regeneration.
Cytoplasmic substrates of Cdh1-APC
Cdh1-APC is predominantly localized to the nucleus where it performs its function, however, it is also found to be active in the pathway [109] . In vivo knockdown of Smurf1 in the developing cerebellum bolstered its role in axon growth regulation and revealed additional defects in neuronal migration [109] .
Just like SnoN and Id2, Cdh1 binds to Smurf1 in a D-box motif-dependent manner to polyubiquitinate Smurf1, which leads to its proteasomal degradation [109] . Consequently, postnatal mouse brain with only one copy of the Cdh1 gene revealed an increase in Smurf1 protein levels [109] . Further experiments also demonstrated a significant stimulation of axon growth by Smurf1-DBM expression in the presence of myelin, indicating that that low levels of Smurf1 contribute to myelin inhibition.
Since the activity of small GTPases such as RhoA is tightly regulated by GAPs (GTPase activating proteins) and GEFs (guanine exchange factors), a candidate screen revealed the RhoGAP p250GAP as a novel interactor of Cdh1 [111] . RhoGAP has previously been shown to act as a GAP for RhoA [112] . In addition to Smurf1, p250GAP was also identified as an axon growth-promoting RhoA regulator in the Cdh1-APC pathway [111] . These studies show that Cdh1-APC in association with p250GAP
and Smurf1 controls RhoA, a key downstream component of extrinsic inhibition ( Figure 3B ). of SnoN DBM led to regeneration of axonal processes into the injury site [114] . Collectively, these studies have validated that substrates of Cdh1-APC hold regenerative potential in spinal cord injuries.
Concluding remarks
By elucidating the Cdh1-APC pathway, it became evident that axon growth inhibition is an active, intrinsic process, highlighting the difficulties that must be overcome in order to 
